Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

49.5K
Overview
49.5K
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.5K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

685
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
685
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.3K
Cancer Vaccines01:30

Cancer Vaccines

665
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
665
Development of Immunocompetence01:22

Development of Immunocompetence

592
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
592

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationship Between Social Determinants of Health and Domains of Care Addressed During Pediatric Palliative Care Visits for Children with Cancer.

Children (Basel, Switzerland)·2025
Same author

Psychological Domains of Care of Pediatric Palliative Care Within Pediatric Oncology.

Psycho-oncology·2025
Same author

The Scope of Clinical Practice of Inpatient and Outpatient Pediatric Palliative Care Within Pediatric Oncology.

Pediatric blood & cancer·2025
Same author

Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomised, double-blind, phase 1/2/3 study.

BMJ open·2024
Same author

Orange maker: a CRISPR/Cas9-mediated genome editing and screening project to generate orange-eyed DarkJedi GAL4 lines by undergraduate students.

Scientific reports·2024
Same author

The Scope of Practice of an Embedded Pediatric Palliative Oncology Clinic.

Journal of pain and symptom management·2023
Same journal

Centering Lived Experience: Inclusive Pediatric Care for Children Who Are Deaf and Hard of Hearing and Their Families.

Pediatric annals·2026
Same journal

From Early Childhood to Adulthood: Implementing Neuroaffirming Health Care for Autistic Individuals.

Pediatric annals·2026
Same journal

Neurodivergence in Medical Education: Current Landscape and Inclusive Future for Pediatrics.

Pediatric annals·2026
Same journal

Neurodiversity and Intellectual Disability: Opportunities and Challenges for Functioning and Participation Across the Life Course.

Pediatric annals·2026
Same journal

Action for Access: Equity for Children With Disabilities in Lowand Middle-Income Countries.

Pediatric annals·2026
Same journal

Rethinking "Healthy" for Every Child: Building Flexible, Family Centered Routines in a Neurodiverse World.

Pediatric annals·2026
See all related articles

Related Experiment Video

Updated: Nov 26, 2025

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.4K

Vaccine Development: From Laboratory to Policy.

Hee Su Park, Eliana L Samuels, Joseph A Bocchini

    Pediatric Annals
    |December 8, 2020
    PubMed
    Summary
    This summary is machine-generated.

    Vaccine development involves rigorous safety and efficacy evaluations before approval. Continuous monitoring ensures vaccine safety post-licensure, crucial for public trust and acceptance, especially during pandemics.

    More Related Videos

    Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
    12:09

    Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

    Published on: May 2, 2011

    43.2K
    Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
    07:44

    Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

    Published on: May 12, 2023

    1.4K

    Related Experiment Videos

    Last Updated: Nov 26, 2025

    Expression and Purification of Virus-like Particles for Vaccination
    06:17

    Expression and Purification of Virus-like Particles for Vaccination

    Published on: June 2, 2016

    22.4K
    Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
    12:09

    Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

    Published on: May 2, 2011

    43.2K
    Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
    07:44

    Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

    Published on: May 12, 2023

    1.4K

    Area of Science:

    • Public Health
    • Immunology
    • Pharmaceutical Sciences

    Background:

    • Vaccines are vital public health tools, yet the development process is often misunderstood.
    • Vaccine hesitancy is a significant challenge, exacerbated by rapid development during the COVID-19 pandemic.

    Purpose of the Study:

    • To review the comprehensive vaccine development process.
    • To explain the safety and efficacy evaluation systems for vaccines.
    • To address public concerns and improve vaccine acceptance.

    Main Methods:

    • Review of the multi-step vaccine development pathway.
    • Description of pre-licensure safety and efficacy evaluations.
    • Explanation of post-licensure safety monitoring systems.

    Main Results:

    • Vaccine development requires extensive testing and collaboration.
    • Robust systems are in place to ensure vaccine safety and effectiveness.
    • Understanding the process is key to addressing hesitancy.

    Conclusions:

    • The rigorous vaccine development and monitoring process prioritizes safety.
    • Improved public understanding can combat vaccine hesitancy.
    • Transparency in vaccine development is essential for public health.